1

GEFTINAT 250MG | GEFTICIP 250MG- Blueberry pharmaceuticals

Geftinat 250mg|Gefticip 250mg is considered as first line therapy in non-small cell lung carcinoma in metastatic stage, tumor cell containing epidermal growth factor receptors like exon 19 deletion or exon 21 substitution mutations which is identified by FDA approved test. #Geftinat250mg #Gefticip250mg #Gefitinib250mg #Iressa


Who Upvoted this Story


Comments